{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T15:40:15Z","timestamp":1773416415393,"version":"3.50.1"},"reference-count":57,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,6,9]],"date-time":"2022-06-09T00:00:00Z","timestamp":1654732800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:sec><jats:title>Objectives<\/jats:title><jats:p>We evaluated the prevalence and risk factors for hepatic steatosis in South African children with perinatally acquired HIV (PHIV) who started treatment early and remain on long-term antiretroviral therapy (ART) compared to HIV-uninfected children.<\/jats:p><\/jats:sec><jats:sec><jats:title>Design<\/jats:title><jats:p>A cross-sectional study from April 2019 to October 2021. PHIV, HIV-exposed uninfected (HEU) and HIV-unexposed (HU) children were enrolled from an ongoing cohort study.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>All children had transient elastography (TE) with controlled attenuation parameter (CAP). Liver enzymes, lipogram, insulin and glucose were sent after an overnight fast. Multivariable linear regression analyses identified predictors of CAP. Hepatic steatosis was defined as CAP&amp;gt;248kPa.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>215 children (111 [52%] male; median age 14.1 years; IQR 12.7\u201314.9) participated in the study, 110 PHIV, 105 HIV-uninfected (36 HEU, 69 HU). PHIV initiated ART at a median age of 2.7 months (IQR 1.8\u20138.5). Hepatic steatosis prevalence was 9% in PHIV, 3% in HEU and 1% in HU children (<jats:italic>p<\/jats:italic> = 0.08). However, 8% of lean (body mass index <jats:italic>z<\/jats:italic>-score  \u2264 +1) PHIV had hepatic steatosis compared to zero lean HEU or HU children (<jats:italic>p<\/jats:italic> = 0.03). In multivariable linear regression analysis of all PHIV, body mass index (BMI) z-score was positively associated with CAP (<jats:italic>p<\/jats:italic> = 0.001) while CD4 count (<jats:italic>p<\/jats:italic> = 0.02) and duration of suppression of HIV viraemia (<jats:italic>p<\/jats:italic> = 0.009) were negatively associated with CAP, adjusting for age, sex and ethnicity.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Hepatic steatosis prevalence was higher in lean PHIV than lean HIV-uninfected South African children. Longer suppression of HIV viraemia and higher CD4 count were associated with lower CAP and might be protective factors for hepatic steatosis in PHIV children.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fped.2022.893579","type":"journal-article","created":{"date-parts":[[2022,6,9]],"date-time":"2022-06-09T05:29:40Z","timestamp":1654752580000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Prevalence and Risk Factors for Hepatic Steatosis in Children With Perinatal HIV on Early Antiretroviral Therapy Compared to HIV-Exposed Uninfected and HIV-Unexposed Children"],"prefix":"10.3389","volume":"10","author":[{"given":"Penelope C.","family":"Rose","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Etienne D.","family":"Nel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark F.","family":"Cotton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard D.","family":"Pitcher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kennedy","family":"Otwombe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara H.","family":"Browne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steve","family":"Innes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,6,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1001\/archinte.166.15.1632","article-title":"Liver-related deaths in persons infected with the human immunodeficiency virus","volume":"166","year":"2006","journal-title":"Arch Intern Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/S2352-3018(15)00179-4","article-title":"Liver disease in patients with HIV in sub-Saharan Africa","volume":"2","author":"Cainelli","year":"2018","journal-title":"Lancet HIV"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1016\/S0140-6736(10)62001-6","article-title":"Increasing burden of liver disease in patients with HIV infection","volume":"377","author":"Joshi","year":"2011","journal-title":"Lancet."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bmjgast-2017-000166","article-title":"Mechanisms of liver disease in patients infected with HIV","volume":"4","author":"Kaspar","year":"2017","journal-title":"BMJ Open Gastro."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1097\/QAD.0000000000002161","article-title":"A gathering storm : HIV infection and nonalcoholic fatty liver disease in low and middle-income countries","volume":"33","author":"Kapoor","year":"2019","journal-title":"AIDS"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1093\/cid\/civ101","article-title":"Nonalcoholic steatohepatitis and hepatic fibrosis in HIV-1 \u2013 monoinfected adults with elevated aminotransferase levels on antiretroviral therapy","volume":"60","author":"Morse","year":"2015","journal-title":"Clin Infect Dis."},{"key":"B7","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1097\/QAI.0b013e318074efe3","article-title":"HIV-positive patients with nonalcoholic fatty liver disease have a lower body mass index and are more physically active than HIV-negative patients","volume":"45","author":"Mohammed","year":"2007","journal-title":"J Acquir Immune Defic Syndr."},{"key":"B8","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1086\/589294","article-title":"Nonalcoholic fatty liver disease in HIV-infected patients referred to a metabolic clinic: prevalence, characteristics, and predictors","volume":"47","author":"Guaraldi","year":"2008","journal-title":"Clin Infect Dis."},{"key":"B9","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/1471-2334-10-116","article-title":"Prevalence and risk factors for significant liver fibrosis among HIV-monoinfected patients","volume":"10","author":"Dallapiazza","year":"2010","journal-title":"BMC Infect Dis"},{"key":"B10","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s40121-018-0229-7","article-title":"A review of non-alcoholic fatty liver disease in HIV- infected patients : the next big thing ?","volume":"8","author":"Welzen","year":"2019","journal-title":"Infect Dis Ther"},{"key":"B11","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s11894-015-0447-z","article-title":"A comprehensive review of noninvasive liver fibrosis tests in pediatric nonalcoholic fatty liver disease","volume":"17","author":"Mansoor","year":"2015","journal-title":"Curr Gasotroenterol Rep."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1007\/s10620-014-3494-7","article-title":"The evaluation of hepatic fibrosis scores in children with nonalcoholic fatty liver disease","volume":"60","author":"Mansoor","year":"2015","journal-title":"Dig Dis Sci [Internet]."},{"key":"B13","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1097\/MPG.0b013e31812e56ff","article-title":"Liver stiffness measurement in children using fibroscan : feasibility study and comparison with fibrotest, aspartate transaminase to platelets ratio index, and liver biopsy","volume":"45","author":"De Ledinghen","year":"2007","journal-title":"J Pediatr Gastroenterol Nutr."},{"key":"B14","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1097\/MPG.0b013e31826f2760","article-title":"Transient elastography is a useful noninvasive tool for the evaluation of fibrosis in paediatric chronic","volume":"56","author":"Fitzpatrick","year":"2013","journal-title":"J Pediatr Gastroenterol Nutr."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1016\/j.jpeds.2013.04.044","article-title":"Serum biomarkers and transient elastography as predictors of advanced liver fibrosis in a united states cohort: the boston children's hospital experience","volume":"163","author":"Lee","year":"2013","journal-title":"J Pediatr."},{"key":"B16","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s00431-011-1558-7","article-title":"Feasibility study and control values of transient elastography in healthy children","volume":"171","author":"Engelmann","year":"2012","journal-title":"Eur J Pediatr"},{"key":"B17","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.jpeds.2016.03.021","article-title":"Comparison of controlled attenuation parameter and liver biopsy to assess hepatic steatosis in pediatric patients","volume":"173","author":"Desai","year":"2016","journal-title":"J Pediatr."},{"key":"B18","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1002\/hep.22376","article-title":"Accuracy and reproducibility of transient elastography for the diagnosis of fibrosis in pediatric nonalcoholic steatohepatitis","volume":"48","author":"Nobili","year":"2008"},{"key":"B19","doi-asserted-by":"publisher","first-page":"4238","DOI":"10.3748\/wjg.v22.i16.4238","article-title":"Transient elastography compared to liver biopsy and morphometry for predicting fibrosis in pediatric chronic liver disease : does etiology matter ?","volume":"22","author":"Behairy","year":"2016","journal-title":"World J Gastroenterol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.clinre.2011.08.001","article-title":"The controlled attenuation parameter (CAP): a novel tool for the non-invasive evaluation of steatosis using Fibroscan \u00ae","volume":"36","author":"Sasso","year":"2012","journal-title":"Clin Res Hepatol Gastroenterol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1111\/j.1478-3231.2012.02820.x","article-title":"Non-invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastography","volume":"32","author":"De Ledinghen","year":"2012","journal-title":"Liver Int."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12876-017-0617-6","article-title":"Noninvasive assessment of liver steatosis in children : the clinical value of controlled attenuation parameter","volume":"17","author":"Ferraioli","year":"2017","journal-title":"BMC Gastroenterol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1056\/NEJMoa0800971","article-title":"Early antiretroviral therapy and mortality among HIV-infected infants","volume":"359","author":"Violari","year":"2008","journal-title":"N Engl J Med"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1056\/NEJMoa1000931","article-title":"Antiretroviral treatment for children with peripartum nevirapine exposure","volume":"363","author":"Palumbo","year":"2010","journal-title":"N Engl J Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"660","DOI":"10.2471\/BLT.07.043497","article-title":"Development of a WHO growth reference for school-aged children and adolescents","volume":"85","author":"De Onis","year":"2007","journal-title":"Bull World Heal Organ."},{"key":"B26","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1097\/MPG.0b013e3181aed725","article-title":"Performance of the AST-to-platelet ratio index as a noninvasive marker of fibrosis in pediatric patients with chronic viral hepatitis","volume":"50","author":"McGoogan","year":"2010","journal-title":"JPGN."},{"key":"B27","doi-asserted-by":"publisher","first-page":"186","DOI":"10.5551\/jat.10.186","article-title":"Assessment of LDL particle size by triglyceride \/ HDL-Cholesterol ratio in non-diabetic, healthy subjects without prominent hyperlipidemia","volume":"10","author":"Maruyama","year":"2002","journal-title":"J Atheroscler Thromb."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.2337\/diacare.23.11.1679","article-title":"Ratio of Triglycerides to HDL cholesterol is an indicator of LDL particle size in patients with Type 2 diabetes and normal HDL cholesterol levels","volume":"23","author":"Boizel","year":"2000","journal-title":"Diabetes Care."},{"key":"B29","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1097\/MPG.0b013e31821b4b61","article-title":"Ultrasonographic quantitative estimation of hepatic steatosis in children with NAFLD","volume":"53","author":"Shannon","year":"2011","journal-title":"J Pediatr Gastroenterol Nutr."},{"key":"B30","doi-asserted-by":"publisher","first-page":"236","DOI":"10.11152\/mu.2013.2066.163.1mlp","article-title":"Noninvasive assessment of liver steatosis using ultrasound methods","volume":"16","author":"Lup\u015for-platon","year":"2014","journal-title":"Med Ultrason"},{"key":"B31","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3390\/children4080073","article-title":"Imaging features of non-alcoholic fatty liver disease in children and adolescents","volume":"4","author":"Martino M","year":"2017","journal-title":"Children"},{"key":"B32","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.jhep.2008.02.008","article-title":"Non-invasive evaluation of liver fibrosis using transient elastography q","volume":"48","author":"Castera","year":"2008","journal-title":"J Hepatol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1093\/infdis\/jiz096","article-title":"Increased prevalence of hepatic steatosis in young adults with lifelong HIV","volume":"220","author":"Aepfelbacher","year":"2019","journal-title":"J Infect Dis"},{"key":"B34","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1097\/QAD.0000000000003170","article-title":"Prevalence of non-alcoholic fatty liver disease using non-invasive techniques among children, adolescents and youths living with HIV","volume":"36","author":"Carrasco","year":"2022","journal-title":"AIDS."},{"key":"B35","doi-asserted-by":"publisher","first-page":"e0226375","DOI":"10.1371\/journal.pone.0226375","article-title":"Nonalcoholic fatty liver disease and hepatic fibrosis among perinatally HIV-monoinfected Asian adolescents receiving antiretroviral therapy","volume":"14","author":"Sudjaritruk","year":"2019","journal-title":"PLoS ONE"},{"key":"B36","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1097\/MPG.0b013e3181a15b72","article-title":"Noninvasive procedures to evaluate liver involvement in HIV-1 vertically infected children","author":"Rubio","year":"2009","journal-title":"J Pediatr Gastroenterol Nutr."},{"key":"B37","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1097\/QAD.0000000000001003","article-title":"Prevalence of and progression to abnormal non-invasive markers of liver disease (APRI and FIB-4) among US HIV-infected Youth","volume":"30","author":"Kapogiannis","year":"2016","journal-title":"AIDS"},{"key":"B38","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1097\/INF.0b013e3182a01dfb","article-title":"Prevalence and predictors of elevated aspartate aminotransferase-to-platelet ratio index in latin American perinatally HIV-infected children","volume":"33","author":"Siberry","year":"2014","journal-title":"Pediatr Infect Dis J"},{"key":"B39","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1097\/INF.0000000000000348","article-title":"Elevated aspartate aminotransferase-to-platelet ratio index in perinatally HIV-infected childrenin the United States","volume":"33","author":"Siberry","year":"2014","journal-title":"Pediatr Infect Dis J"},{"key":"B40","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1186\/s12879-018-3115-8","article-title":"HBV and HIV viral load but not microbial translocation or immune activation are associated with liver fibrosis among patients in South Africa","volume":"18","author":"Maponga","year":"2018","journal-title":"BMC Infect Dis."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/MD.0000000000002127","article-title":"Liver fibrosis in HIV patients receiving a modern cART","volume":"94","author":"Mohr","year":"2015","journal-title":"Medicine."},{"key":"B42","doi-asserted-by":"publisher","first-page":"12309","DOI":"10.1038\/s41598-017-11489-2","article-title":"Prevalence and predictors of liver disease in HIV-infected children and adolescents","volume":"7","author":"Pokorska-\u015bpiewak","year":"2017","journal-title":"Nat Sci Rep"},{"key":"B43","doi-asserted-by":"publisher","first-page":"e0191118","DOI":"10.1371\/journal.pone.0191118","article-title":"Exposure to previous cART is associated with significant liver fibrosis and cirrhosis in human immunodeficiency virus-infected patients","volume":"18","author":"Anadol","year":"2018","journal-title":"PLoS ONE"},{"key":"B44","doi-asserted-by":"publisher","first-page":"e25201","DOI":"10.1002\/jia2.25201","article-title":"Predictive factors associated with liver fibrosis and steatosis by transient elastography in patients with HIV mono-infection under long-term combined antiretroviral therapy","volume":"21","author":"Perazzo","year":"2018","journal-title":"J Int AIDS Soc."},{"key":"B45","doi-asserted-by":"publisher","first-page":"271","DOI":"10.14740\/gr913w","article-title":"Non-alcoholic fatty liver disease in africa and middle east : an attempt to predict the present and future implications on the healthcare system","volume":"10","author":"Ahmed","year":"2017","journal-title":"Gastroenterol Res."},{"key":"B46","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat Rev Gastro Hepatol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ofid\/ofv015","article-title":"Incidence and predictors of hepatic steatosis and fibrosis by serum biomarkers in a large cohort of human immunode fi ciency virus mono-infected patients","volume":"2","author":"Sebastiani","year":"2015","journal-title":"Open Forum Infect Dis."},{"key":"B48","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.cgh.2017.09.041","article-title":"Racial and ethnic disparities in non-alcoholic fatty liver disease prevalence, severity, and outcomes in the United States: a systematic review and meta-analysis","volume":"16","author":"Rich","year":"2018","journal-title":"Clin Gastroenterol Hepatol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/gheg.2019.2","article-title":"Non-alcoholic fatty liver disease in Africa : a hidden danger","volume":"4","author":"Paruk","year":"2019","journal-title":"Glob Heal Epidemiol Genomics."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1002\/hep.27710","article-title":"A clinicopathological cohort study of liver pathology in 301 patients with human immunodeficiency virus\/acquired immune deficiency syndrome","volume":"61","author":"Sonderup","year":"2015","journal-title":"Hepatology."},{"key":"B51","doi-asserted-by":"publisher","first-page":"e0117813","DOI":"10.1371\/journal.pone.0117813","article-title":"Tuberculosis and hepatic steatosis are prevalent liver pathology findings among HIV-infected patients in South Africa","volume":"10","author":"Hoffmann","year":"2015","journal-title":"PLoS ONE"},{"key":"B52","doi-asserted-by":"publisher","first-page":"S79","DOI":"10.1097\/QAI.0000000000000260","article-title":"Noncommunicable diseases in HIV infection in low- and middle-income countries: gastrointestinal, hepatic, and nutritional aspects","volume":"67","author":"Kelly","year":"2014","journal-title":"J Acquir Immune Defic Syndr."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S2352-4642(20)30037-7","article-title":"Chronic comorbidities in children and adolescents with perinatally acquired HIV infection in sub-Saharan Africa in the era of antiretroviral therapy","volume":"4642","author":"Frigati","year":"2020","journal-title":"Lancet Child Adolesc Heal."},{"key":"B54","doi-asserted-by":"publisher","first-page":"e0217415","DOI":"10.1371\/journal.pone.0217415","article-title":"Hepatitis B sero-prevalence in children under 15 years of age in South Africa using residual samples from community-based febrile rash surveillance","volume":"14","author":"Prabdial-sing","year":"2019","journal-title":"PLoS ONE"},{"key":"B55","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/S2468-1253(17)30249-2","article-title":"Viral hepatitis in sub-Saharan Africa 2 Hepatitis C in sub-Saharan Africa : the current status and recommendations for achieving elimination by 2030","volume":"2","author":"Sonderup","year":"2017","journal-title":"Lancet Gastroenterol Hepatol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12887-020-02479-x","article-title":"Viral hepatitis B and C in HIV-exposed South African infants","volume":"20","author":"Tchuem","year":"2020","journal-title":"BMC Pediatr."},{"key":"B57","doi-asserted-by":"publisher","first-page":"29","DOI":"10.10520\/EJC-159842e372","article-title":"Guidelines for the use of transient elastography in South Africa","volume":"17","author":"Sonderup","year":"2019","journal-title":"South African Gastroenterol Rev."}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2022.893579\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,9]],"date-time":"2022-06-09T05:29:43Z","timestamp":1654752583000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2022.893579\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,9]]},"references-count":57,"alternative-id":["10.3389\/fped.2022.893579"],"URL":"https:\/\/doi.org\/10.3389\/fped.2022.893579","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,9]]},"article-number":"893579"}}